Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
33.33
-0.38 (-1.13%)
At close: Apr 28, 2026, 4:00 PM EDT
33.35
+0.02 (0.06%)
After-hours: Apr 28, 2026, 5:00 PM EDT
Stoke Therapeutics Employees
Stoke Therapeutics had 170 employees as of December 31, 2025. The number of employees increased by 42 or 32.81% compared to the previous year.
Employees
170
Change (1Y)
42
Growth (1Y)
32.81%
Revenue / Employee
$1,084,824
Profits / Employee
-$40,500
Market Cap
2.08B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 835 |
| Galapagos NV | 558 |
| Ocular Therapeutix | 325 |
| Syndax Pharmaceuticals | 298 |
| Zymeworks | 264 |
| Capricor Therapeutics | 231 |
| Pharvaris | 129 |
| Aurinia Pharmaceuticals | 128 |
STOK News
- 12 days ago - Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Business Wire
- 14 days ago - Stoke Therapeutics Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 20 days ago - Stoke Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference - Business Wire
- 21 days ago - Stoke Therapeutics Appoints Clare Kahn, Ph.D., to its Board of Directors - Business Wire
- 7 weeks ago - The New England Journal of Medicine Publishes First Data to Demonstrate the Potential for Disease Modification in Dravet Syndrome - Business Wire
- 2 months ago - Stoke Therapeutics Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Stoke Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference - Business Wire
- 2 months ago - Stoke Therapeutics Transcript: Guggenheim Securities Emerging Outlook: Biotech Summit 2026 - Transcripts